IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q2 2024 Holdings

Filed 2024-08-09 | 3 holdings | $202.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$164.7M19,201,47581.5%
Pliant Therapeutics, Inc.(PLRX)COM729139105$22.9M2,132,86711.3%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$14.5M2,343,1547.2%